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Abstract
Background. Gitelman disease presents with musculos-
keletal complaints and fatigue. Surprisingly, there is no
clear-cut correlation between biochemical abnormalities
and symptoms.
Methods. Starting from the hypothesis that the way
patients comprehend their illness within their sociocultur-
al frameworks reﬂects on their way of adapting to it, this
study investigated how adult patients experience the
disease in everyday life. We conducted a qualitative
analysis based on interviews with 12 patients. Interviews
were audio recorded, fully transcribed and analyzed using
the constant comparative method described by Strauss
and Corbin.
Results. A typology of the experiences emerged from the
data and was tested on each transcript with an explicit
search for disconﬁrming cases. Patients fell into four
main groups: (i) those considering Gitelman disease a
disabling illness, (ii) those considering it a normalized
illness, (iii) those considering it a different normality and
(iv) those considering it an episodic disability. Each
pattern of experience was characterized by particular (i)
ways of interpreting symptoms (ii) ways of managing
Gitelman disease in everyday life, (iii) general lifestyles
and (iv) risks for the patient’s psychosocial life.
Conclusions. These ﬁndings suggest that health care
providers should take advantage of considering patients’
own perception of the disease in order to adjust the care
and advice provided.
Keywords: Gitelman disease; hereditary disease; hypokalaemia; quality
of life
Introduction
Mutations in the gene encoding the sodium chloride co-
transporter in the distal convoluted tubule cause Gitelman
disease. This disorder is characterized by hypokalaemia,
alkalosis, hypomagnesaemia, hypocalciuria and normal
blood pressure [1, 2].
It is traditionally assumed that on supplementation with
potassium and magnesium, Gitelman disease is character-
ized by a relatively mild course and that affected subjects
are asymptomatic [1, 2]. However, the two studies that
speciﬁcally addressed the quality of life of Gitelman
patients provide discrepant results. A study conducted
among children shows that the illness does not adversely
interfere with subjects’ mood or social relationships [3].
This is in contrast with the results of an inquiry among
affected adults, indicating an increased prevalence of
reported symptoms [4].
It is tempting to assume that in Gitelman disease,
quality of life is inﬂuenced by the patient’s age and
gender, by mutation type, by regulatory or modiﬁer
genes, by intake of salts and by correction by other tubule
segments [1, 2, 4, 5]. In addition to the factors mentioned,
the interpretive sociological paradigm provides an original
and interesting key for understanding, as it suggests that
the way patients comprehend their illness within their so-
ciocultural frameworks reﬂects on their way of adapting
to it [6].
Based on this hypothesis, we undertook a qualitative
study to explore how young adult patients subjectively
experience their illness in daily life. Speciﬁcally, this
paper pursues four objectives: to illustrate how partici-
pants describe and give meaning to symptoms, to high-
light the strategies they use to manage their illness, to
illustrate the impact of illness on their daily life and iden-
tity and to describe the psychosocial risks correlated with
Gitelman disease experience.
Materials and methods
The study population consisted of 12 unrelated Italian Gitelman patients
(seven female and ﬁve male subjects, aged 20–37 years). The diagnosis
had been made ≥5 years before the present study and was based on the
following criteria [7]: normal blood pressure, hypokalaemia and hypo-
magnesaemia of renal origin, increased urinary chloride excretion and
reduced urinary calcium excretion. Biallelic mutations in the gene encod-
ing the thiazide-sensitive sodium chloride cotransporter had been ident-
iﬁed in 11 patients. The manifestation of the disease, established using
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the criteria of Riveira-Munoz et al. [5], was severe in 4 of the
12 patients.
We conducted a qualitative study based on in-depth interviews with
the aforementioned 12 patients, according to our standard procedure
[8–10], based on the Grounded Theory approach [11]. Grounded Theory
is a research method that works in a reverse way from traditional re-
search. Rather than beginning with a hypothesis, the ﬁrst stage is data
collection. From these data, the key elements are marked with a series of
codes. These are grouped into similar concepts. From these concepts, cat-
egories are formed, which are the basis for the creation of a theory [11].
Participants were current or former patients of one of the authors
(A.B.) and were living in northern Italy. We limited the recruitment to
this geographical area in order to collect data in a homogeneous socio-
cultural context. Variability of respondents’ experience was ensured by
the diversiﬁcation of the sample in terms of gender, age and education.
Approval for the whole study was granted by the governing Ethical
Committee and informed consent was obtained.
Interviews were conducted between October 2009 and May 2010.
After attending the laboratory for the measurement of plasma potass-
ium and total magnesium levels [7], the participants were asked to de-
scribe their experience in the order and manner desired. However, to
make sure all the points were covered, we prepared an interview grid
with the main topics to be treated: illness trajectory, difﬁculties, coping
strategies, resources, patient–physician relationship, representation of
symptoms and medications, daily activities, social networks, social and
personal identity. Interviews lasted about 1 h, were audio recorded
and transcribed. During transcription, pseudonyms were given to
participants.
Analysis was facilitated by the use of the software Atlas.ti [12]. Con-
sistent with the Grounded Theory approach, data collection and analysis
were parallel processes and were performed by one of the authors (M.C.
Z.). However, the researchers engaged in regular discussions on emer-
ging patterns to ensure analytical rigor.
A four-folder typology of Gitelman disease experience in daily life
was progressively developed and tested on each transcript with an expli-
cit search for disconﬁrming cases. Processes underlying the different
types of experience were also identiﬁed. At the end, an overall tendency
to saturation was observed, i.e. information from the last interviews
tended to be redundant, conﬁrming thus the emergent theoretical model.
This paper focuses on part of this model by describing the four-folder
typology of Gitelman disease experience.
Results
Analysis reveals four ways of experiencing Gitelman
disease in daily life: as a disabling illness, as a normalized
illness, as a different form of normality and as an episodic
disability.
Each pattern of experience is characterized by a speciﬁc
way of interpreting symptoms, i.e. of perceiving fre-
quency, intensity, and distress of symptoms, and of giving
meaning to them. Based on symptoms interpretation,
patients develop peculiar ways of managing their con-
dition in everyday life. They also develop peculiar life-
styles, i.e. stable patterns of behaviour that reﬂect
their personal philosophy of life. Finally, each pattern of
Gitelman disease experience is characterized by some
correlated risks for the patients’ psychosocial life. Table 1
summarizes these patterns and the corresponding clinical
and laboratory data.
In the following, we illustrate each pattern of Gitelman
disease experience through the description of a speciﬁc
case.
Alfred: Gitelman disease as a disabling illness
Symptoms interpretation: persistent invasive troubles.
The main symptom Alfred perceives is invasive
exhaustion. He is unable to realize projects important to
him (such as going out with friends) or to assume his
daily responsibilities (such as attending school or work
regularly). Alfred is focused on his illness and tends to
interpret any sign of fatigue as a consequence of the
disease. Health is, for him, the ideal condition, i.e. the
absence of any nuisance. Assigning a pathological origin
to his tiredness, Alfred feels powerless and anxious about
his future.
Illness management: over-/undercompliance. In the
hope to improve his fatigue, Alfred overcomplies with
medical advice. He often takes more supplements than
prescribed and follows general medical suggestions as
absolute rules. However, being unsatisﬁed with the results
of his efforts, Alfred tends to become discouraged. Thus,
sometimes he ‘transgresses’ his rules to see whether
something changes: ‘I have never done physical exercise
because the doctor discouraged me. But now I’m ﬂying in
his face because I go to the gym. I want to see how I feel.
I think that he does not agree, because this makes me
sweat, but… ’
Lifestyle: disrupted life. Alfred describes his life as
characterized by important restrictions: ‘I feel constrained
by the illness. I dislike my life, because sometimes I feel
that I have energy to burn, but I stay quiet: if then I get
sick?’ Beside restrictions, Alfred considers that he has
many obligations: medication taking, medical consultation
and diet. Thus, Alfred considers Gitelman disease as dis-
rupting his life and everyday routine, at home, at work
and in leisure time. Gitelman disease also inﬂuences his
self-perception and ideas about the future. Alfred has
strong feelings of impotence and defeat and tends to
assume a self-pitying attitude: ‘I go on, what else can I
do? My father tells me: “console yourself, you are not the
only one”. But why the hell should I care? (… ) If I had
nothing, I would be happier’. Ultimately, Alfred does not
accept the disease and is unable to integrate it into his
life.
Risk: chaotic activism. Confronted with symptoms, he
is neither able to manage nor able to accept; Alfred’s
main wish is to ﬁnd a deﬁnitive medical solution. Over
the years, he has consulted several health professionals,
and he has tried complementary/alternative medicine. His
risk is to accumulate attempts for resolving the situation
and to be systematically frustrated, alternating this way
feelings of hope and despair.
Bertha: Gitelman disease as a normalized illness
Symptoms interpretation: well-controlled troubles.
Bertha does not experience strong symptoms. She only
reports a general sense of lack of energy and, more rarely,
pins and needles in her hands. Despite this lack of symp-
toms, Bertha has a strong sick identity. ‘I don’t think I’m
like others who have nothing. A healthy person does not
have to do all these things’. The disease is seen as a
medical condition because of medical treatments. Bertha
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Table 1. Patterns of disease experience and clinical and laboratory data in 12 unrelated Italian patients affected with Gitelman disease (seven female and ﬁve male subjects, aged 20–37 years)
Disabling illness, Alfred Normalized illness, Bertha Different normality, Clark Episodic disability, Debora
Symptoms interpretation Persistent invasive troubles Well-controlled troubles Insigniﬁcant troubles Episodic signiﬁcant troubles
Illness management Over-/undercompliance Absolute compliance Self-management Collaborative management
General lifestyle Disrupted life Slowed-down life Ordinary life Vigilant life
Correlated risks Chaotic activism Unquestioning passivity Illness banalization Medical dependency
N 2 1 7 2
Female gender 0 1 4 2
Age (years)
Current 23, 24 25 20, 22, 24, 28, 31, 33, 36 28, 37
At diagnosis 13, 17 10 5, 6, 9, 12, 15, 15, 17 6, 7
Disease severea (N) 0 1 1 2
Mutations in the gene encoding the sodium
chloride cotransporter (Nucleotide level, protein
effect)
c.2899A>G, p.Arg967Gly
homozygous;
c.2542G>A, p.Asp848Asn/
c.506-1G>A, splice site
c.557G>A, p.Gly186Asp/
c.625C>T, p.Arg209Trp
c.184G>A, p.Asp62Asn homozygous;
c.557G>A, p.Gly186Asp/c.1742T>A,
p.Met581Lys homozygous;
c.2295de1, p.Phe765LeuX10;
c.1046C>T, p.Pro349Leu/c.1432A>G,
p.Lys478Glu; c.2191del, p.
Gly731GlyX3/c.1315G>A, p.
Gly439Ser; c.1742T>A, p.Met581Lys
homozygous; no mutations detected
c.1625T>C, p.Leu542Pro; c.1388G>A,
p.Gly463Glu/c.1844C>T, p.Ser615Leu
Current plasma level
Potassium (mmol/L) 2.6; 2.7 2.9 2.5, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0 2.7; 3.1
Magnesium (mmol/L) 0.61; 0.69 0.52 0.41; 0.43; 0.44; 0.50; 0.52; 0.60;
0.65
0.50; 0.52
Current drug Management Potassiumb (N = 2), amiloride
(N = 2), magnesium (N = 1)
Potassiumb and magnesium Potassiumb (N = 7), spironolactone
(N = 1)
Potassiumb (N = 2), amiloride
(N = 1), magnesium (N = 1)
aCriteria suggested by Riveira-Munoz et al. [5].
bAs potassium chloride.
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considers them both the essential condition for her normal
functioning and the marker of her illness.
Illness management: absolute compliance. Bertha con-
siders that her role in managing illness is to thoroughly
comply with her doctor’s instructions. She is extremely
diligent: she regularly goes to the specialist, she limits her
sweating and she neither forgets to take supplements nor
changes the amount of medication absorbed. Ultimately,
Bertha does not take any initiative: her compliant attitudes
and behaviours aim at maintaining the status quo, avoid-
ing any possible danger.
Lifestyle: slowed-down life. Bertha is satisﬁed with her
life. She considers restrictions and obligations related to
her illness as mild constraints. Therefore, she describes
her lifestyle as perfectly normal. Despite her perception
of normality, however, Bertha’s efforts to cope with her
illness inﬂuence her life rhythm: this is slowed down to
adapt to the management rules she follows. For example,
Bertha accepted a job which she was over-qualiﬁed for as
a saleswoman as it is close to home and causes no stress.
Risk: unquestioning passivity. Bertha executes medical
recommendations without trying to understand them. For
example, she has avoided any physical activity since
childhood because the doctors had told her to be careful:
‘The doctors told me: “if you take medications and then
you do physical exercise, that makes you sweat, it would
be better to avoid it (… ).” They told me: “do it until
when you feel tired, then stop.” So I told myself: it’s
better if I don’t do anything. Instead of exercising and dis-
covering that tests aren’t good and then I have to take
more medication, I prefer doing nothing at all’. Her way
of experiencing and managing illness, characterized by
lack of reﬂexivity, risks leading her to a passive attitude in
terms of self-management.
Clark: Gitelman disease as a different normality
Symptoms interpretation: insigniﬁcant troubles. Clark
reports occasional episodes of sleepiness and cramps.
Nonetheless, he interprets these troubles as insigniﬁcant
incidents. He considers that any human being is faced
with some health problems. Thus, his perception of health
is wide enough to include these mild nuisances. ‘Clearly
one would prefer to be ﬁt as a ﬁddle. But as there are so
many things that can go amiss in our body, this is the best
to have’. Clark also considers his symptoms as the normal
consequence of his activities. ‘When I say that I am tired,
my mother immediately asks me: “have you taken the
pills?” But what the hell has this to do with the pills? I
am tired because I do many things!’
Illness management: self-management. Clark manages
his illness mainly autonomously. The medical specialist
played a central role when the situation was unstable, but
nowadays, Clark takes his blood test periodically in a
public laboratory and interprets the results alone. He con-
sults the specialist only in case of signiﬁcant changes in
his biochemical values or in preparation for particular
events (trips, surgical intervention). He has obtained
several prescriptions from his general practitioner to build
up a supply of medications. Additionally, Clark makes
day-to-day decisions concerning the treatment, based on
how he feels, on his life constraints and personal values.
For example, sometimes he does not take medication
because he does not want to draw people’s attention. He
also develops some personal strategies to cope with symp-
toms (i.e. eating chocolate). If necessary, he is able to
accept symptoms without dramatizing. He is convinced
that he has learned to evaluate his body and therefore he
is able to take some reasonable risks.
Lifestyle: ordinary life. Clark strongly defends his ordin-
ary identity. He underlines that his life not only is normal
but also hyperactive and overbooked. Clark pursues his
ambitions without being constrained by his illness,
leading an enriched life where there is no place for the
sick identity. Additionally, his way of managing illness
makes his contact with medical institutions rare, fortifying
this way his identity as a healthy person living a
normal life.
Risk: illness banalization. Clark tends to forget that he
has an illness that needs to be kept under control. For
example, he reports that he regularly forgets to take pills.
‘I am so involved in the normality of life that I almost
forget that I have it (… ). The most difﬁcult thing is to
remember to swallow the pills’. Moreover, Clark is so
self-conﬁdent that he admits not having consulted a
doctor for years.
Debora: Gitelman disease as an episodic disability
Symptoms interpretation: sporadic signiﬁcant troubles.
Like Clark, Debora considers that she sometimes suffers
from unimportant, occasional troubles (sleepiness,
cramps). Differently from Clark, however, Debora has to
face the memory of traumatic experiences related to Gitel-
man disease: on four occasions, she suffered from tetanic
crises due to ﬂu or hot weather, and she had to go to the
hospital for mineral salt injections. During these attacks,
Debora was confronted with several problems: physical
(during the crisis, she was at risk of heart attack), sensor-
ial (the attack was painful), aesthetic (she suffered from
paralysis leaving her with deformed features), psychologi-
cal (she felt extremely anxious), social (she found it difﬁ-
cult to explain her illness at the ﬁrst-aid station because of
its rarity), and functional (she could hardly move and
speak). ‘I couldn’t drive: with the paraesthesia you are so
rigid that you feel like a trunk! You really can’t move,
you can’t even do a phone call! I thought: if nobody does
anything, what will I do? (… .) My sister brought me
straight to the hospital for injections. And every time I
have to pass the same stupid procedure. Last time I got
angry. “What are you doing?” [to the doctors]. “We are
searching your illness in the computer” “And what about
asking me? I just need a little bit of potassium!”’
Illness management: collaborative management. Debora
is not especially worried about mild symptoms such as
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sleepiness and cramps. She manages them by taking basic
precautions, such as taking her medications regularly and
avoiding activities which cause excessive sweating. On the
contrary, she is extremely worried about tetanic crises. Her
efforts are mainly oriented to preventing and limiting them.
She monitors her body to recognize warning signs. She
organizes her life to be ready to face eventual crisis: she
informs her friends about what to do in case of crisis, she
always carries a detailed description of her illness and treat-
ment in her wallet, etc. This way of managing illness is not
an individual activity: to realize it, Debora needs the collab-
oration of her family, of her friends and of her doctor.
Lifestyle: vigilant life. Debora describes her life as
normal. Despite her perception of normality, however, her
efforts to prevent and limit her crises involve a price to
pay: the price of continuous vigilance. Gitelman disease
does not concretely inﬂuence Debora’s activities.
However, it forces her to continuous self-observation and
planning for the worst.
Risk: medical dependency. To manage her tetanic crises,
Debora requires the collaboration of her family and of her
doctor. Even if she does not ask for help, she needs to
know that she can count on them. Otherwise, she feels
lost and in danger. Thus, Debora tends to avoid unfamiliar
contexts. For example, going on vacation is stressful, and
changing doctor is inconceivable. Ultimately, the risk of
her way of managing Gitelman disease is developing a
kind of dependency, especially on her doctor: ‘I am
always in contact with him. I really don’t know what I
would do without him’.
Discussion
In Gitelman disease, the clinical manifestations include
musculoskeletal complaints, which are traditionally due to
hypokalaemia and hypomagnesaemia, and fatigue, which
might be more common in patients with greater degrees of
salt wasting. However, there is little or no correlation
between, on the one side, the manifestations and, on the
other side, either extra- or intracellular electrolyte levels or
increased release of prostaglandins [1, 2]. Our data
suggest that patients affected by Gitelman disease very
heterogeneously experience this genetic disease in their
daily life: as a disabling illness, as a normalized illness, as
a different form of normality or as an episodic disability.
Surprisingly, we did not observe any correlation
between severity of the clinical manifestations [5] and ex-
pressed quality of life. For instance, the manifestations
were mild in patients who consider Gitelman disease a
disabling illness (Table 1). Consistent with the interpretive
approach, however, our study was not built up to make
statistical correlations but to understand the previous
experience of the individuals. Our results show that
patients’ personal interpretation of symptoms play a role
in the diversiﬁcation of the experiences.
While we are not able to state that the four patterns of
experience identiﬁed are exactly the same in other dis-
eases, several studies have observed that patients with a
same chronic condition can experience their illness in
very different ways, according to how they make sense of
it [8, 13–16]. In chronic conditions, indeed, patients’
interpretation of illness is particularly important. Chronic
sufferers live in the so-called ‘dual kingdoms of the well
and the sick’ [17]. Being sick, but asked to live ‘as nor-
mally as possible’ [18], they have to place themselves in
between these two extremities.
In Gitelman disease, the uncertainty concerning the
meaning of the illness is even more evident. Not only is
this a chronic disease, but, although it is well deﬁned at a
biomolecular level, it appears particularly ambiguous from
a phenomenological point of view: symptoms (cramps and
fatigue) can be seen as pathological conditions or as usual
experiences, while treatment (potassium and magnesium)
can be considered as pharmacological medication or as or-
dinary dietary supplementation. Thus, since Gitelman
disease contains elements of both illness and wellness,
people have a particularly wide margin of interpretation of
their health condition.
In our study, the majority of participants interpret Gitel-
man disease as a different kind of normality. Though the
qualitative nature of the investigation does not allow for
statistical generalization, it seems that most young adults
are little affected by the illness.
This study has the advantage of being the ﬁrst in-depth
investigation of daily experience of Gitelman patients using
validated qualitative research techniques [19]. It also pro-
vides a good example of the potential gulf between
‘medical’ and ‘social’ models of disease. However, it has
limitations which are unavoidable with investigations on
rare phenomena. The Grounded Theory approach [11]
suggests that data collection and analysis continue until
data saturation. The rarity of the disease, however, meant
that we stopped after 12 interviews as new data could only
have been collected in other geographical contexts. Signs
of saturation were already evident, but some further data
would have provided more details on the developed typol-
ogy, and in particular, on the pattern ‘normalized illness’,
which is constituted by only one person.
Despite this limitation, ﬁndings suggest interesting
paths for future research and clinical practice. Concerning
research, it will be useful to explore what inﬂuences the
experiences of Gitelman disease. Our ongoing analysis
suggests that pivotal are the kind of support provided by
patients’ family, and patients’ personality traits. It will
also be worth investigating the transferability of our four-
folder typology to other chronic diseases. Concerning
clinical practice, these results underline that health care
providers would beneﬁt from considering patients’ own
perception of the disease in order to adjust the care and
advice provided. Patients who experience Gitelman
disease as a disabling illness could be encouraged to dis-
tinguish normal from pathological tiredness; patients who
experience the disease as normalized illness should be
trained to evaluate their situation day-by-day and to diver-
sify their strategies of management; patients who experi-
ence the disease as different normality should be warned
about the importance of medical care; ﬁnally, patients
who experience the disease as an episodic disability could
be helped in planning strategies to manage tetanic crises.
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Abstract
Background. The metabolic syndrome (MS) is associ-
ated with increased prevalence of kidney stones, yet the
speciﬁc stone type remains largely unknown. This study
was conducted to assess whether risk factors associated
with calcium nephrolithiasis increase with individual
characteristics of the MS.
Methods. A retrospective analysis was performed in 109
non-stone-forming subjects and 128 recurrent calcium
stone formers from Dallas, Texas. A separate analysis was
performed in 140 recurrent calcium stone formers from
Bern, Switzerland. Demographic, anthropometric, serum
and urinary proﬁles were measured.
Results. In non-stone formers from Dallas, urinary
calcium (3.6 ± 1.8 to 6.0 ± 2.9 mmol/day, P = 0.0003 for
trend, zero to four features) increased with increasing fea-
tures of the MS. This change was attendant with a signiﬁ-
cant rise in supersaturation index (SI) of calcium oxalate
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